Figures & data
Table 1 Clinical Characteristics of Enrolled Subjects, Hospitalized Patients with CDI and Non-CDI Group
Table 2 Antimicrobial Susceptibility of 28 Toxigenic C. difficile Isolates
Table 3 Minimum Inhibitory Concentrations of 28 Toxigenic Isolates to Vancomycin and Metronidazole
Table 4 Comparison of Population Numbers of Selected Microbial Groups in Case (CDI Patients) and Control (Hospitalized Patients without Diarrhea) Studied Groups Participated in This Study